ABSTRACT
Background
In the field of aesthetic medicine there is an increasing demand for safe and effective hyaluronic acid (HA) fillers to counteract the aging process.
Methods and Aims
We designed a study to evaluate the safety and histological biocompatibility of Aliaxin® Global Performance, a cross-linked HA filler and Viscoderm® Skinkò E, a product composed of non-cross-linked HA and a complex including vitamins, antioxidants, amino acids and minerals injected into the skin of guinea pigs. Then, we translated our findings into the clinical setting, administering a combination of these compounds to patients seeking a facial rejuvenation procedure targeting moderate-to-severe wrinkles affecting the nasolabial folds.
Results
The animal study showed that the two compounds did not induce any significant inflammatory reactions and increased collagen and elastic fibers in the skin. In the clinical setting, injection of Aliaxin® Global Performance, followed by Viscoderm® Skinkò E, resulted in a higher improvement in nasolabial fold hydration, trans-epidermal water loss and wrinkle aesthetic appearance, if compared with a protocol based on Aliaxin® Global Performance alone.
Conclusion
In summary, we show evidence on the safety and mechanism underlying two new HA-based compounds of different cross-linkage and composition, proposing that they can be safely used in combination in patients seeking facial rejuvenation procedures with long-lasting efficacy.
Similar content being viewed by others
Abbreviations
- Aliaxin® GP:
-
Aliaxin® Global Performance
- BDDE:
-
1,4-Butanediol diglycidyl ether
- CLHA:
-
Cross-linked HA
- HA:
-
Hyaluronic acid
- HE:
-
Hematoxylin and eosin
- HPF:
-
High-power field
- N:
-
Newton
- NCLHA:
-
Non-cross-linked HA
- PBS:
-
Phosphate buffered saline
- PWBC:
-
Polymorphonuclear white blood cells
- SEM:
-
Standard error of the mean
- TEWL:
-
Trans-epidermal water loss
- TGF-β:
-
Transforming growth factor beta
- Viscoderm® SE:
-
Viscoderm® Skinkò E
- WSRS:
-
Wrinkle severity rating scale
REFERENCES
Nemoto T, Kubota R, Murasawa Y, Isogai Z. Viscoelastic properties of the human dermis and other connective tissues and its relevance to tissue aging and aging–related disease, viscoelasticity - from theory to biological applications. In: De Vicente J, editor. ISBN: 978-953-51-0841-2, InTech. doi:10.5772/50146. 2012. Available from: http://wwwintechopencom/books/viscoelasticity-from-theory-to-biological-applications/viscoelastic-properties-of-the-human-dermis-and-other-connective-tissues-and-its-relevance-to-tissue.
Agache P, Humbert P. Measuring the skin. Germany: Springer-Verlag Berlin Heidelberg; 2004.
Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. 2008;144(5):666–72.
Varani J, Dame MK, Rittie L, Fligiel SE, Kang S, Fisher GJ, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;168(6):1861–8.
Iannitti T, Palmieri B. Inflammation and genetics: an insight in the centenarian model. Hum Biol. 2011;83(4):531–59.
Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, et al. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg Off Publ Am Soc Dermatol Surg [et al]. 2013;39(2):205–31.
Sood V, Nanda S. Patient Satisfaction with Hyaluronic Acid Fillers for Improvement of the Nasolabial Folds in Type IV & V Skin. J Maxillofac Oral Surg. 2012;11(1):78–81.
Cartier H, Trevidic P, Rzany B, Sattler G, Kestemont P, Kerrouche N, et al. Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips. J Drug Dermatol: JDD. 2012;11(1 Suppl):s17–26.
Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22(5):335–41. discussion 341–333.
Eccleston D, Murphy DK. Juvederm((R)) Volbella in the perioral area: a 12-month prospective, multicenter, open-label study. Clin Cosmet Investig Dermatol. 2012;5:167–72.
Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg: FPS. 2009;25(2):86–94.
Iannitti T, Capone S, Palmieri B. Short review on face rejuvenation procedures: focus on preoperative antiseptic and anesthetic delivery by JetPeel-3 (a high pressure oxygen delivery device). Minerva Chir. 2011;66(3 Suppl 1):1–8.
Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs. 1994;47(3):536–66.
Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release: Off J Control Release Soc. 1998;53(1–3):93–103.
Redbord KP, Busso M, Hanke CW. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther. 2011;24(1):71–81.
Iannitti T, Elhensheri M, Bingol AO, Palmieri B. Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis. J Mol Histol. 2013;44(2):191–201.
Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drug R&D. 2011;11(1):13–27.
Iannitti T, Rottigni V, Palmieri B. A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis. Int J Immunopathol Pharmacol. 2012;25(4):1093–8.
Palmieri B, Rottigni V, Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Dev Ther. 2013;7:7–12.
Littara A, Palmieri B, Rottigni V, Iannitti T. A clinical study to assess the effectiveness of a hyaluronic acid-based procedure for treatment of premature ejaculation. Int J Impot Res. 2013;25(3):117–20.
Iannitti T, Rottigni V, Torricelli F, Palmieri B. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study. Clin Appl Thromb Hemost: Off J Int Acad Clin Appl Thromb/Hemost. 2014;20(3):326–30.
Iannitti T, Bingol AO, Rottigni V, Palmieri B. Biocompatibility and rheological properties of a new highly viscoelastic hyaluronic acid in a rat model for biomaterial implants and first-in-man clinical investigation in esthetic and restorative medicine. Int J Pharm. 2013. doi:10.1016/j.ijpharm.2013.06.066.
Ardizzoni A, Neglia RG, Baschieri MC, Cermelli C, Caratozzolo M, Righi E, et al. Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. J Mater Sci Mater Med. 2011;22(10):2329–38.
Cermelli C, Cuoghi A, Scuri M, Bettua C, Neglia RG, Ardizzoni A, et al. In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virol J. 2011;8:141.
Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012;7:1441–7.
Arsiwala SZ. Safety and persistence of non-animal stabilized hyaluronic Acid fillers for nasolabial folds correction in 30 Indian patients. J Cutan Aesthet Surg. 2010;3(3):156–61.
Quan T, Wang F, Shao Y, Rittie L, Xia W, Orringer JS, et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Investig Dermatol. 2013;133(3):658–67.
Turlier V, Delalleau A, Casas C, Rouquier A, Bianchi P, Alvarez S, et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: In vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J Dermatol Sci. 2013;69(3):187–94.
Day DJ, Littler CM, Swift RW, Gottlieb S. The wrinkle severity rating scale: a validation study. Am J Clin Dermatol. 2004;5(1):49–52.
Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain: Off J Am Pain Soc. 2003;4(7):407–14.
Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg: Off Publ Am Soc Dermatol Surg [et al]. 1998;24(12):1317–25.
Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg. 2003;27(5):354–66. discussion 367.
Niechajev I. Lip enhancement: surgical alternatives and histologic aspects. Plast Reconstr Surg. 2000;105(3):1173–83. discussion 1184–1177.
Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol. 2006;154(4):755–8.
Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930–3.
Rongioletti F, Cattarini G, Sottofattori E, Rebora A. Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol. 2003;139(6):815–16.
Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg Off Publ Am Soc Dermatol Surg [et al]. 2001;27(2):185–91.
Tung R, Ruiz de Luzuriaga AM, Park K, Sato M, Dubina M, Alam M. Brighter eyes: combined upper cheek and tear trough augmentation: a systematic approach utilizing two complementary hyaluronic acid fillers. J Drug Dermatol: JDD. 2012;11(9):1094–7.
Iannitti T, Rottigni V, Palmieri B. Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures. Drug Des Dev Ther. 2013;7:1035–41.
ACKNOWLEDGMENTS AND DISCLOSURES
This article was not supported by grants. JCMM acknowledges CONACyT for membership.
TI, JCM, AC and BP contributed equally to every part of this work including design and conduction of clinical and experimental studies as well as statistical analysis and drafting of the article.
The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript. We thank IBSA Farmaceutici Italia for the donation of Viscoderm® Skinko’ E and Aliaxin® Global Performance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iannitti, T., Morales-Medina, J.C., Coacci, A. et al. Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin. Pharm Res 33, 2879–2890 (2016). https://doi.org/10.1007/s11095-014-1354-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1354-y